• Planned launch Q3:23 by Scilex Pharmaceuticals
  • For more details, visit www.gloperba.com
  • Only FDA approved oral solution for the prophylactic treatment of gout flares in adults
  • 0.6mg/5mL Colchicine
  • Liquid dosage form provides dosing flexibility
Learn More

Gout: A Growing Problem

  • Gout affects 8.3 million people in the United States.
  • Many patients remain undiagnosed due to limited disease awareness
  • Gout patient numbers are expected to increase due to the aging population
Learn More
  • Planned launch Q3:23 by Scilex Pharmaceuticals
  • For more details, visit www.gloperba.com
  • Only FDA approved oral solution for the prophylactic treatment of gout flares in adults
  • 0.6mg/5mL Colchicine
  • Liquid dosage form provides dosing flexibility
Learn More

Gout: A Global Problem

  • Gout affects 8.3 million people in the United States.
  • Many patients remain undiagnosed due to limited disease awareness
  • Gout patient numbers are expected to increase due to the aging population
Learn More
  • Planned launch Q3:23 by Scilex Pharmaceuticals
  • For more details, visit www.gloperba.com
  • Only FDA approved oral solution for the prophylactic treatment of gout flares in adults
  • 0.6mg/5mL Colchicine
  • Liquid dosage form provides dosing flexibility
Learn More

Gout: A Global Problem

  • Gout affects 8.3 million people in the United States.
  • Many patients remain undiagnosed due to limited disease awareness
  • Gout patient numbers are expected to increase due to the aging population
Learn More

ROMEG News